About: http://data.cimple.eu/news-article/ea9cee47eb06da4ce9d39d076a7236fe6b437df004f6d8d751915d17

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/ea9cee47eb06da4ce9d39d076a7236fe6b437df004f6d8d751915d17 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Russian officials said Friday a European review of the country's Sputnik V coronavirus vaccine is going "according to plan" and the jab may be approved in the coming months, local news agencies reported. Sputnik V has been registered in more than 65 countries but has yet to be approved by the European Medicines Agency (EMA) or the United States' Food and Drug Administration (FDA). "Everything is going according to plan," Health Minister Mikhail Murashko told journalists on the sidelines of the Saint Petersburg Economic forum. "We haven't received any critical questions so I think the work is going to plan, we are waiting for results," Murashko said. Kirill Dmitriyev, head of the Russian Direct Investment Fund that helped fund the development of the jab, said the "registration time depends on the EMA". "A normal working process is underway, which we hope will not be politicised," Dmitriyev added. Deputy health minister Sergei Glagolev said the vaccine may receive the approval of the EMA and of the World Health Organization (WHO) in the next few months. Moscow registered Sputnik -- named after the Soviet era satellite -- in August ahead of large-scale clinical trials. But trial results published in the respected The Lancet medical journal have said it is safe and with two doses is more than 90 percent effective in symptomatic cases. The EMA launched a rolling review of the vaccine in March but several EU countries have already approved the jab. Russia has registered four homegrown vaccines -- Sputnik V, EpiVacCorona, CoviVac and in May Sputnik Light. While Russia's domestic vaccination campaign started in early December ahead of most countries, the country has struggled to innoculate its citizens. Polls show that many Russians are sceptical of coronavirus vaccines. acl/mm/yad
schema:headline	Russia optimistic about European approval of Sputnik jab
schema:mentions	Saint Petersburg Medical journal European Medicines Agency Sputnik 1 Soviet Union Satellite The Lancet Jab Moscow World Health Organization Food and Drug Administration European Union Russia Russian language Vaccine United States Severe acute respiratory syndrome coronavirus 2 European Review Dmitriyev (town) Patriarch Kirill of Moscow Russian Direct Investment Fund Anterior cruciate ligament Yad
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-06-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	77 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software